Paola Favuzza - Concepedia

Author

Paola Favuzza

Walter and Eliza Hall Institute of Medical Research ORCID

Also Known As

Brodie Bailey, Favuzza, Paola, P. Favuzza, Paola Favuzza

Publications

558

Citations

H-Index

Concepts

All Affiliations

Walter and Eliza Hall Institute of Medical Research Swiss Tropical and Public Health Institute The University of Melbourne University of Basel Medicines for Malaria Venture

About

Paola Favuzza is an author at Walter and Eliza Hall Institute of Medical Research specializing in drug discovery, drug resistance, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	66
2	Pharmacology	3	3	66
3	Drug Discovery	3	3	66
4	Biomolecular Engineering	2	2	39
5	Immunology	1	1	27

Paola Favuzza

Publications

541

Citations

H-Index

Page 1

	Year	Citations
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle Paola Favuzza, Manuel de Lera Ruiz, Jennifer K. Thompson, Cell Host & Microbe	2020	159
Passive Immunoprotection of <i>Plasmodium falciparum</i>-Infected Mice Designates the CyRPA as Candidate Malaria Vaccine Antigen Anita M. Dreyer, Hugues Matile, Petros Papastogiannidis, The Journal of Immunology	2012	75
Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibody Paola Favuzza, Elena Guffart, Marco Tamborrini, eLife	2017	72
7-<i>N</i>-Substituted-3-oxadiazole Quinolones with Potent Antimalarial Activity Target the Cytochrome <i>bc</i><sub>1</sub> Complex William Nguyen, Madeline G. Dans, Iain Currie, ACS Infectious Diseases	2023	29
Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivax Anthony N. Hodder, Janni Christensen, S.W. Scally, Structure Plasmepsin IxDrug SelectivityAntiparasitic AgentMedicineMalaria	2022	27
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of <b>UCB7362</b> Martin A. Lowe, Á. de Pablo Cárdenas, Jean‐Pierre Valentin, Journal of Medicinal Chemistry	2022	27
Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against Plasmodium falciparum parasites in preclinical in vitro and in vivo models Marco Tamborrini, Julia Hauser, Anja Schäfer, npj Vaccines	2020	25
Generation of Plasmodium falciparum parasite-inhibitory antibodies by immunization with recombinantly-expressed CyRPA Paola Favuzza, Simon Blaser, Anita M. Dreyer, Malaria Journal	2016	22
Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4 Trent D. Ashton, Madeline G. Dans, Paola Favuzza, Journal of Medicinal Chemistry	2023	22
Property activity refinement of 2-anilino 4-amino substituted quinazolines as antimalarials with fast acting asexual parasite activity Trent D. Ashton, Anna Ngo, Paola Favuzza, Bioorganic Chemistry Property Activity RefinementAntifungal AgentAsexual Parasite ActivityAntiparasitic AgentMedicine	2021	20

Page 1